Abstract |
Malignant tumors are the second major cause of death in Germany. The essential therapy of operable cancer is surgical removal of primary tumors combined with adjuvant therapy. However, several consequences of surgery may promote metastasis, such as shedding of tumor cells into the circulation, decrease in tumor-induced antiangiogenesis factors, excessive release of growth factors for wound healing and suppression of immunity induced by surgical stress. In the last decade it has become clear that cell-mediated immunity controls the development of metastasis. Various perioperative factors, such as surgical stress, certain anesthetic and analgesic drugs and pain can suppress the patients' immune system perioperatively. On the other hand, by modifications of the anesthesia technique (e.g. regional anesthesia) and perioperative management to minimize immunosuppression, anesthesiologists can play a considerable role for a better outcome in patients having malignant tumors. Sufficient clinical evidence is not yet available to prove or disprove the hypothesis that anesthesia practice can improve cancer prognosis. Despite difficulties in study design, several prospective randomized trials are currently running and the results are awaited to elucidate this topic.
|
Authors | K Fukui, C Werner, G Pestel |
Journal | Der Anaesthesist
(Anaesthesist)
Vol. 61
Issue 3
Pg. 193-201
(Mar 2012)
ISSN: 1432-055X [Electronic] Germany |
Vernacular Title | Beeinflussung maligner Tumoren durch Anästhesieverfahren. |
PMID | 22430549
(Publication Type: English Abstract, Journal Article, Review)
|
Topics |
- Anesthesia
(adverse effects)
- Humans
- Immunity, Cellular
(immunology)
- Neoplasm Metastasis
(pathology, prevention & control)
- Neoplasms
(complications, immunology, surgery)
- Postoperative Complications
(physiopathology, therapy)
- Prognosis
- Randomized Controlled Trials as Topic
- Stress, Physiological
- Treatment Outcome
|